Cellphire Therapeutics
Dr. Moskowitz has 25 years of leadership experience directing research and development (R&D) and strategy in companies with revenues of more than $1 billion. He has held technical, management, and liaison positions in the areas of hemostasis and thrombosis, infectious, and genetic diseases in a variety of medical industries, including biologicals
Previously, Dr. Moskowitz served as Vice President of Technology and Development at PTS Diagnostics; Vice President of Product Development & Medical Science Liaison at TraumaCure; Vice President of Product Development at BioMarker Strategies; and Director of Corporate Product Development at SeraCare Life Sciences. He also served as Director of Hematology and R&D at Adlyfe and Accumetrics.
Dr. Moskowitz received a Bachelor of Science from Rutgers University and a Ph.D. in Biochemistry from Temple University School of Medicine. He is the author of more than 50 peer reviewed publications, abstracts, and patents and is a member of the American Society of Hematology; The International Society for Hemostasis and Thrombosis; and the American Association of Clinical Pathologists.
This person is not in any offices
Cellphire Therapeutics
3 followers
Cellphire Therapeutics, Inc. is a Rockville, Maryland-based biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology to all cell types, including platelets, to develop lifesaving products.